Skip to content

Effect of Constraint-Induced Movement Therapy along with conventional therapy and conventional therapy alone on upper extremity spasticity in children with Cerebral Palsy.

Effect of Constraint-Induced Movement Therapy along with conventional therapy and conventional therapy alone on upper extremity spasticity in children with Cerebral Palsy.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220411054500N1
Enrollment
46
Registered
2022-04-29
Start date
2022-04-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy (CP) is a disorder characterized by abnormal muscle tone, postural disabilities and movement disorders due to predominant motor syndrome. Constraint-induced movement therapy (CIMT) is referred to be an effective intervention that aid to improve motor functioning in hemiplegic cerebral palsy.. G80.9 is the ICD-10 code for Cerebral palsy.

Interventions

Intervention 1: Intervention group : Constraint Induced Movement Therapy and Conventional Therapy Group. Intervention 2: Control group: Conventional therapy group.

Sponsors

Faisal Institute of Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age 4-12 years Both genders. Children with diagnosed upper extremity spastic cerebral palsy. Children with minimum grade 1+ on modified ashworth scale

Exclusion criteria

Exclusion criteria: ?Children with Intellectual disability Children who had concomitent sight and hearing disabilities Children with previous six months history of hand surgery. Children with uncontrolled seizures?Children with severe health problems not typically associated with CP Children with contractures that limited functional arm and hand use

Design outcomes

Primary

MeasureTime frame
The modified Ashworth scale will be used as the primary outcome variable to assess the level of spasticity. Timepoint: 3 timepoints including baseline measurement (week 0), 2nd week post treatment and 4th week post treatment. Method of measurement: The modified Ashworth scale will be used to measure level of spasticity.

Secondary

MeasureTime frame
Quality of Life Questionnaire for Children (CP QOL-Child) is a secondary outcome variable that is useful for evaluating Quality of Life. Timepoint: Timepoint include 3 points including baseline measurement (week 0), 2nd week post treatment and 4th week post treatment. Method of measurement: The CP QOL-Child is used to assess the quality of life of children aged 4-12 years.

Countries

Pakistan

Contacts

Public ContactDr. Tehreem Jameel

Faisal Institute of Health Sciences

tehreemclick123@gmail.com+92 41 8536999

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026